Latka logo
NewLimit logo

NewLimitrevenue

United StatesFounded 2022

NewLimit is a biotechnology company that focuses on extending human healthspan through epigenetic reprogramming of cells. The company develops innovative medicines to restore youthful function in old cells.

newlimit.comLinkedInUpdated Sep 10, 2026
Annual revenue
$4.6M
Sep 2025EST
Employees
40
Sep 2025

NewLimit revenue

NewLimit has not published its revenue. Growjo puts it at about $4.6M a year (September 2025).

$0
$2M
$4M
$0
–
$4.6M
20222023–242025
ReportedEstimateFounded 2022 at $0; every reading has its own bar
As ofRevenueSource
Sep 2025$4.6MESTGrowjo estimate

NewLimit employees

NewLimit has 40 employees (September 2025, LinkedIn).

0
10
20
30
40
40
2025
ReportedOne figure per year; a reported figure wins over an estimate

NewLimit FAQ

What is NewLimit's revenue?

Growjo estimates NewLimit's revenue at about $4.6M a year (September 2025). The company hasn't published its own figure.

How many employees does NewLimit have?

NewLimit has 40 employees as of September 2025, according to LinkedIn.

Categories

Companies in

How this page is sourced

1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun NewLimit? Join the podcast